27 November 2024 - The MHRA has approved the medicine flortaucipir (Tauvid), given to adults with memory problems so that doctors can perform a type of brain scan called a PET.

This approval is supported by evidence from a diagnostic performance study, in which it was shown that PET scans identified 92% of the patients who had significant buildup of tau protein (which are abnormal clusters of protein fragments that build up between nerve cells) as positive.

Read UK Government press release